6-14-10 Daily Small Cap Market News and Stock Highlights from SmallCapVoice.com

Stocks are higher amid strong European economic data

Stocks rose on Monday, boosted by technology and industrial shares after strong euro zone industrial data reassured investors the global economic rebound is on track.

European shares hit a four-week high after April euro zone industrial output surged at the biggest pace year-on-year in almost two decades, easing concerns that a slowdown in Europe could curb global growth.

A burst of short-covering also helped lift the euro as sentiment toward risky assets improved. The common currency has been a barometer for European stability, with U.S. stocks tracking its movements.

Oil futures climbed 2.3 percent to $75.51 per barrel on renewed optimism about a recovery.

The Dow Jones industrial average rose 74.37 points, or 0.73 percent, to 10,285.44. The Standard & Poor’s 500 Index added 8.22 points, or 0.75 percent, to 1,099.82. The Nasdaq Composite Index gained 22.91 points, or 1.02 percent, to 2,266.51.

Yesterday’s Top Performing Small Cap Stock:

VizStar, Inc. VIZS

VizStar Inc. was a SmallCapVoice.com top performer yesterday closing up over 6% on trading volume of 50,375 shares.

Celestial Jets is the fastest growing premier aviation charter broker delivering a new and unprecedented way to experience private travel. As one of the foremost aviation charter brokers, Celestial Jets is built around two core assets, its brand and its people. These assets have built the foundation for Celestial Jets, allowing them to become as diverse as the institutions, communities, and individuals that they serve.

Today’s SmallCapVoice.com Hot Stock to Watch:

Sillenger Exploration Corp. SLGX

Fugro Retained by Sillenger for Airborne Geophysical Survey of Equatorial Guinea

TORONTO — (Marketwire) — 06/14/10 — Sillenger Exploration Corp. (“Sillenger”) SLGX SLGX is pleased to announce that it has retained the services of Fugro Airborne Surveys Corp to conduct the airborne geophysical survey of the Rio Muni region of Equatorial Guinea. The upcoming survey will help to reveal the locations of potential deposits, and provide a detailed reading of the subsurface structures.

Read More >>

SmallCapVoice Clients’ News

BRAVADA International Ltd (Pink Sheets: MFLI)

BRAVADA Schedules Investor’s Conference Call for Wednesday June 16 with CEO Danny Alex Regarding Positive Material Developments

Jun. 14, 2010 (Business Wire) — BRAVADA Muscle Flex Inc. (www.MuscleFlex.com) (Pink Sheets:MFLI) announced today that will be conducting an investor conference call with CEO Danny Alex on Wednesday June 16 instead of the previously announced June 22 to disclose a number of significant positive material developments. The conference call shall take place at 3:00 PM PT. Investor call in information is as follows:

Phone: 712-432-0075
Access Number: 432665

Read More >>


Other Small Cap News

Angiotech Pharmaceuticals, Inc. ANPI

Angiotech’s licensee, Cook Medical, files PMA submission for FDA approval of Zilver(R) PTX(R) Drug-Eluting Stent platform

VANCOUVER, June 11 /PRNewswire-FirstCall/ – Angiotech Pharmaceuticals, Inc. ANPIANP today announced Cook Medical, a license holder of Angiotech’s paclitaxel technology, has submitted its Pre-Market Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for the company’s unique polymer-free Zilver(R) PTX(R) Drug-Eluting Peripheral Stent. Intended for use in patients with peripheral arterial disease (PAD) in the superficial femoral artery (SFA), Zilver PTX is a self-expanding, highly durable nitinol stent that uses a proprietary, polymer-free technology to deliver a locally therapeutic dose of paclitaxel, an anti-proliferative drug, to the target lesion.

Read More >>


Allos Therapeutics, Inc. ALTH

Allos Therapeutics’ FOLOTYN Shows Activity and Tolerability in Phase 1 Dose Finding Study in Patients with Relapsed or Refractory CTCL

New Data Presented at 15th Annual EHA Meeting Demonstrates Responses to FOLOTYN in Patients Failing Prior Systemic Therapies

BARCELONA, Spain & WESTMINSTER, Colo.–(BUSINESS WIRE)–Allos Therapeutics, Inc. ALTH today announced updated data from its ongoing dose finding Phase 1 study of FOLOTYN® (pralatrexate injection) in patients with relapsed or refractory cutaneous T-cell lymphoma (CTCL), a group of often slow-growing non-Hodgkins lymphomas that primarily manifest in the skin. These data were presented during a poster presentation at the European Hematology Association (EHA) meeting being held June 10-13, 2010 in Barcelona, Spain.

Read More >>


Lucas Energy, Inc. (NYSE Amex: LEI)

Lucas Energy Announces Five Workover Rigs Running in Eagle Ford Trend

HOUSTON, June 11, 2010 (GLOBE NEWSWIRE) — Lucas Energy, Inc. (NYSE Amex:LEI), an independent oil and gas company (the “Company”) based in Houston, Texas, today announced that the Company has five (5) workover rigs running in the Eagle Ford – Austin Chalk Trend area. Three of the workover rigs are working on re-entries of old, abandoned wells, and one of the workover rigs is drilling a new lateral in the Austin Chalk formation. The Company will log and/or test the Eagle Ford formation in at least three wells within the next month.

Read More >>


Hyperdynamics Corporation (NYSE Amex: HDY)

Hyperdynamics Announces Results of 3D Seismic Tender

HOUSTON, June 11 /PRNewswire-FirstCall/ — Hyperdynamics Corporation (NYSE Amex: HDY) today announced that it has contracted with PGS Geophysical to conduct the acquisition phase of a 3D seismic survey on its offshore block in the Republic of Guinea. Following a thorough technical and commercial review of the seven bids received in the May tender, Hyperdynamics awarded the contract to the Norwegian-based firm. The 3,500 square kilometer survey will be acquired over two separate portions of the contract area with the intention of obtaining detailed imaging of the multiple prospects which were identified from the prior 2D seismic data.

Read More >>


Javelin Pharmaceuticals, Inc. (NYSE Amex: JAV)

Javelin gets $2 million loan from Hospira

Javelin Pharmaceuticals receives $2 million loan from Hospira under existing deal

CAMBRIDGE, Mass. (AP) — Javelin Pharmaceuticals said Friday that Hospira funded a $2 million loan to the company.

Hospira funded the loan on June 10 under an existing agreement between the companies.

The companies are currently embroiled in a lawsuit over a buyout plan.

Read More >>


Timberline Resources Corporation (NYSE Amex: TLR)

Timberline Announces Timberline Drilling Contract Extension and Provides Update on Drilling Services

COEUR D’ALENE, Idaho, June 14, 2010 (GLOBE NEWSWIRE) — Timberline Resources Corporation (NYSE Amex:TLR) (TSX-V:TBR) (“Timberline”) is pleased to announce that its contract core drilling subsidiary, Timberline Drilling, has entered into a three-year extension to its existing underground and surface drilling contract with its largest customer. Timberline Drilling’s contract now extends into 2014 which provides revenue stability and aids in the retention of quality staff and drillers by providing steady work for the company and its employees.

Read More >>


Arotech Corporation ARTX

Arotech Receives Over $10 Million in Follow on Orders for Davids and Aircraft Armor

ANN ARBOR, MI–(Marketwire – 06/14/10) – Arotech Corporation ARTX, a provider of quality defense and security products for the military, law enforcement and security markets, announced today that its Armor Division has received orders valued at more than

Read More >>


Micromet, Inc. MITI

Micromet’s Blinatumomab Induces Durable Remissions in Patients with Relapsed Non-Hodgkin’s Lymphoma

BETHESDA, Md., June 14 /PRNewswire-FirstCall/ — Micromet, Inc. MITI today announced the presentation of updated results from a Phase 1 trial of the Company’s lead product candidate blinatumomab (MT103) in patients with relapsed non-Hodgkin’s lymphoma (NHL). A high objective response rate was maintained among patients treated with blinatumomab using an adapted schedule, comparable to that previously reported in patients receiving constant dosing. Blinatumomab is the first in a new class of agents called BiTE® antibodies, designed to harness the body’s T cells to kill cancer cells.

Read More >>


Intellicheck Mobilisa, Inc. (NYSE Amex: IDN)

Joint Readiness Training Center Military Base Awards Contract to Intellicheck Mobilisa

Fort Polk Adds to Defense ID System

PORT TOWNSEND, Wash.–(BUSINESS WIRE)–Intellicheck Mobilisa, Inc. (NYSE AMEX: IDN), a global leader in access control and wireless security systems, received a contract from the US Army at Fort Polk to provide them with additional Defense ID ® access control equipment. The value of the contract is nearly $200,000 for additional equipment, software, installation, training and warranties.

Read More >>

About SmallCapVoice.com

SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide. Known for its ability to help emerging growth companies build a following among retail and institutional investors, SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its client’s financial news releases. SmallCapVoice.com also offers individual investors with all the tools they need to make informed decisions about the stocks they are interested in. Tools like our stock charts, stock alerts, and our investor fact sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets.

Small Cap Voice SCV is an electronic publication, and is for informational purposes only. The stocks profiled by SCV are only company profiles and are not intended to be and should not be accepted by you as recommendations to buy or sell in these securities. These profiles are compiled from publicly available sources. Our sources include, but are not limited to, online research, company profiles, member suggestions, magazines, newspapers, analyst suggestions, broker recommendations, contact with the company, company rumors, press releases and other similar information sources. All profiles are based on information that is accessible by the public. Investing in stocks involves risk. SCV is not and does not hold itself out to be a registered broker or dealer or other licensed securities professional. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. For compensation and complete disclaimer click here.

Contact:

Stuart T. Smith CEO
512-267-2430
ssmith@smallcapvoice.com
http://www.smallcapvoice.com

Related posts

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Industrial MachineryIndustrials
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!